We examined the expression levels of KRAS, COPB2, NCOR1 and SPRY1 across the five colorectal adenocarcinoma cell lines available in TCGA's cBioPortal (www.cbioportal.org) [24, 25] (Supplementary Figure 2). This evidence concerns the gene SPRY1 and colorectal adenocarcinoma.